• Measure Summary
  • NQMC:009390
  • 2013 Nov

Sickle cell disease (SCD): percentage of children with a newborn screen positive for SCD who receive appropriate preventive antibiotics by 3 months of age.

  • Measure Summary
  • NQMC:010921
  • 2016 May

Cervical cancer screening: age standardized incidence rate per 100,000 women of invasive cervical cancer—non-squamous cell carcinoma diagnosed in a year.

  • Measure Summary
  • NQMC:010907
  • 2016 May

Cervical cancer screening: percentage of eligible women who have a subsequent Pap test within 3 years (36 months) of the index test with a negative result.

  • Measure Summary
  • NQMC:009388
  • 2013 Oct

Sickle cell disease (SCD): percentage of children who, having initially tested positive for SCD through newborn screening, received confirmatory testing by 3 months of age.

  • Measure Summary
  • NQMC:010910
  • 2016 May

Cervical cancer screening: percentage of women with a negative ASCUS, LSIL, AGC, ASC-H, HSIL or more severe Pap test result.

  • Measure Summary
  • NQMC:010919
  • 2016 May

Cervical cancer screening: percentage of women with histology of HSIL per 1000 women who had a Pap test in the previous 12 months.

  • Measure Summary
  • NQMC:010922
  • 2016 May

Cervical cancer screening: percentage of invasive carcinoma of the cervix diagnosed at stage 1 in a 12-month period.

  • Measure Summary
  • NQMC:010908
  • 2016 May

Cervical cancer screening: percentage of eligible women who have a subsequent Pap test within 42 months of the index test with a negative result.

  • Measure Summary
  • NQMC:010905
  • 2016 May

Cervical cancer screening: percentage of eligible women with at least one Pap test in a 3-year frame.

  • Measure Summary
  • NQMC:009389
  • 2013 Oct

Sickle cell disease (SCD): percentage of children whose confirmatory testing results were communicated to their families by 4 months of age.